| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $33.1M | — | +2.6% |
| SG&A Expense | $17.4M | — | +173.7% |
| Operating Income | -$50.5M | — | -39.8% |
| Interest Expense | $4.5M | — | +40.6% |
| Pre-tax Income | -$52.8M | — | -42.8% |
| Net Income | -$52.8M | — | -42.8% |
| EPS (Basic) | -$0.97 | — | -12.8% |
| EPS (Diluted) | -$0.97 | — | -12.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $145.2M | -12.4% | +781.1% |
| Short-term Investments | $241.9M | -12.3% | +27.8% |
| Current Assets | $408.9M | -12.2% | +87.9% |
| Total Assets | $410.2M | -12.1% | +88.0% |
| Current Liabilities | $33.2M | -24.8% | +0.9% |
| Long-term Debt | $137.9M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$55.1M | — | -53.6% |
| Capital Expenditures | $249K | — | +315.0% |
| Investing Cash Flow | $34.5M | — | +42.3% |
| Financing Cash Flow | $34K | — | -99.4% |
| Free Cash Flow | -$55.3M | — | -54.0% |
| +30.9% |
| Total Liabilities | $356.6M | -2.6% | +171.3% |
| Stockholders' Equity | $53.5M | -46.8% | -38.2% |